2017 Annual Meeting | C226 - How to Integrate Sleep Medicine into Your Child Neurology Practice

Date Friday 04/28/17

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Suresh Kotagal, MD, FAAN

Topic(s) Child Neurology and Developmental Neurology

Learning Objectives Participants should be able to understand components of a sleep-focused history and examination and become aware of the utility and limitations of common sleep laboratory diagnostic procedures; appreciate the bi-directional relationship between sleep and epilepsy; understand how enhancing sleep can improve the quality of life in neurodevelopmental disorders such as autism; and learn about how improving sleep impacts childhood headache syndromes.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
07:00 AM - 07:25 AM	Speaker	Clinical and Sleep Laboratory Assessment Suresh Kotagal, MD, FAAN
07:25 AM - 07:50 AM	Speaker	Research and Clinical Practice: Sleep in Neurodevelopmental Disabilities Kiran P. Maski, MD
07:50 AM - 08:15 AM	Speaker	Epilepsy and Sleep—Common Bedfellows Sanjeev V. Kothare, MD, FAAN
08:15 AM - 08:40 AM	Speaker	The Relationship Between Headache and Sleep Sejal V. Jain, MD
08:40 AM - 08:55 AM	Q&A	Questions and Answers
08:55 AM - 09:00 AM	Closing Remarks	Closing Remarks Suresh Kotagal, MD, FAAN

Faculty Disclosures
Suresh Kotagal, MD, FAAN	No disclosure on file
Sanjeev V. Kothare, MD, FAAN	Dr. Kothare has nothing to disclose.
Kiran P. Maski, MD	An immediate family member of Dr. Maski has received personal compensation for serving as an employee of Sanofi Genzyme. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KemPharm. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hayes Legal Services. An immediate family member of Dr. Maski has stock in Sanofi Genzyme. The institution of Dr. Maski has received research support from Jazz Pharmaceuticals. The institution of Dr. Maski has received research support from NIH 5K23NS104267-2. The institution of Dr. Maski has received research support from Coverys. Dr. Maski has received publishing royalties from a publication relating to health care.
Sejal V. Jain, MD	Dr. Jain has nothing to disclose.

��ɫ��

��ɫ��